Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Antimicrobial Treatment for Buruli Ulcer Effective In Early, Limited Disease - (DGNews)
    US FDA Approves First Nonsurgical Treatment for Adult Dupuytren's Contracture - (DGNews)
    Immune Cell Levels Predict Skin Cancer Risk in Kidney Transplant Patients - (DGNews)
    Health Canada Approves Imiquimod Cream for Actinic Keratosis - (DGNews)
    Heart Transplant Patients Appear to Have Elevated Risk for Multiple Skin Cancers - (DGNews)

    News archive

     Recent webcasts/CME - Dermatology Other
      Tuberous Sclerosis
      Advances in the Treatment of Actinic Keratosis: Evidence-Based Approaches for Optimized Outcomes
      Adverse Cutaneous Reactions Induced by TNF-[alpha] Antagonist Therapy
      Advancements in Enzymatic Debridement: Applying Clinical Science to Everyday Applications
      The Prevention and Treatment of Pressure Ulcers

      Webcasts/CME archive

       Recent cases - Dermatology Other
        Sclerodermiform Porphyria Cutanea Tarda
        A Rare Case Of Pulmonary Tuberculosis With Simultaneous Pulmonary And Skin Sarcoidosis: A Case Report
        Metastatic Breast Cancer Deluding As A Papular Skin Rash
        Leser-Trelat Syndrome In Patients Affected By Six Multiple Metachronous Primitive Cancers
        Spontaneous Regression of Metastatic Merkel Cell Carcinoma

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Narrow-Band UVB Treatment of Vitiligo Leads to High Levels of Patient, Physician Satisfaction: Presented at CDA

        By Pam Harrison

        TORONTO, CANADA -- July 6, 2007 -- Patients with vitiligo and physicians appear to be highly satisfied with the results of narrow-band ultra-violet B (UVB) light therapy, according to a retrospective review.

        Jean-Pierre DesGroseilliers, MD, professor of medicine, University of Ottawa, Ottawa, Ontario, Canada, and colleagues reviewed results in the first 50 patients treated for vitiligo with narrow-band UVB at the Photoderm Clinic in Ottawa.

        Patients' mean age at onset of vitiligo was 31 years, and the mean age at treatment was 41.4 years. The majority of patients were skin types 3, 4, and 5, with only a small number having skin types 1 and 2.

        The researchers classified outcomes based on percent repigmentation of melanocytes, judged as "poor" at 0 to 33%, "good" at 33% to 66%, or "very good" at 66% to 100%.

        The study findings were presented in a poster session here on July 1st and 2nd during the Canadian Dermatology Association 82nd Annual Conference (CDA).

        More than 70% of vitiligo in the face had a "very good" response to treatment, as did approximately 60% of areas on the body.

        A much lower success rate was seen when vitiligo affected the hands or feet, with only 10% of vitiligo in these areas achieving a very good response.

        Patient and physician satisfaction with results were very similar with approximately half of both patients and physicians indicating they considered treatment responses "very good," while approximately 20% felt treatment response was "good."

        Dr. DesGroseilliers notes in an interview that the cause of vitiligo is unknown, although it is thought to be an autoimmune disease, where the melanocytes that produce pigment in the skin stop functioning.

        "It can happen at any age," he noted, "both in children and later on in life, and what we do with the light is we try to stimulate those melanocytes that are still present at the bottom of the hair follicle which, once turned on, start multiplying and repigment the skin." This strategy does not work well in vitiligo of the hands or feet, although there are exceptions, based on the Ottawa groups' experience, he says.

        Adverse effects include itching and pain, as well as erythema, burns (especially to the nipples), blistering of the lips, and reactivation of herpes simplex.

        Narrow-band UBV is not appropriate for patients with very pale skin, as it darkens normal skin and tends to make vitiligo more visible. Nevertheless, narrow-band UVB is the safest of the current phototherapy modalities, Dr. DesGroseilliers notes.

        It is the only modality that really works in this condition, he says, as neither psoralen combined with ultraviolet light A nor cortisone creams have produced responses that made patients or physicians happy.

        "You never get 100% repigmentation," says Dr. DesGroseilliers, "but if patients respond to this treatment in a clinic setting, you may wish to prescribe the home unit, depending on their circumstances."

        Third-year medical student Sonya Abdulla from the University of Ottawa and lead author on the poster, also felt that narrow-band UBV is "definitely worth considering, especially considering the impact the disease can have on a person's self esteem and mental health."

        If patients do opt for the home unit, it is recommended they start off with five treatments per week, tapering down to three times per week as improvement occurs.


        [Presentation title: Treatment of Vitiligo With Narrow-Band Ultra-Violet B (NB-UVB) Advantages and Disadvantages.]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send